Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin Metabolite Ratios in Myotoxicity
NCT00414531Phase 4Completed
- Sponsor
- University of Oslo School of Pharmacy
- Start
- May 2005
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in hypercholesterolemia, sponsored by University of Oslo School of Pharmacy. Started May 2005; status: completed.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00414531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414531.